In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Hydrochloride, Paroxetine Drug Master File in Korea (Hydrochloride, Paroxetine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hydrochloride, Paroxetine. The MFDS reviews the Hydrochloride, Paroxetine KDMF as part of the drug registration process and uses the information provided in the Hydrochloride, Paroxetine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Hydrochloride, Paroxetine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hydrochloride, Paroxetine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Hydrochloride, Paroxetine suppliers with KDMF on PharmaCompass.